2025-522495-84-00
Not yet recruiting
Phase 1/2
A Clinical study of MK-4716 in people with certain solid tumors (MK-4716-001)
Merck Sharp & Dohme LLC3 sites in 1 country29 target enrollmentStarted: December 23, 2025Last updated:
Overview
- Phase
- Phase 1/2
- Status
- Not yet recruiting
- Sponsor
- Merck Sharp & Dohme LLC
- Enrollment
- 29
- Locations
- 3
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (18-64 Years, 65+ Years)
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Marie Will
Scientific
Merck Sharp & Dohme LLC
Study Sites (3)
Loading locations...
Similar Trials
Recruiting
Phase 1
A clinical study of MK-6916 in healthy people (MK-6916-006)2025-521487-36-00Merck Sharp & Dohme LLC40
Recruiting
Phase 1
A clinical study of MK-6050 in healthy people (MK-6050-001)2025-523861-58-00Merck Sharp & Dohme LLC32
Completed
Phase 1
A clinical study of MK-2828 in healthy people (MK-2828-001)2024-513377-51-00Merck Sharp & Dohme LLC16
Not yet recruiting
Phase 1
A Phase 1 study of GSK5764227 in participants with advanced solid tumors2024-513663-10-01Glaxosmithkline Research & Development Limited, Glaxosmithkline Research & Development Limited112
Recruiting
Phase 1
A clinical study of MK-4646 in people with HIV (MK-4646-003)2025-521102-17-00Merck Sharp & Dohme LLC14